Found: 22
Select item for more details and to access through your institution.
Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of <sup>225</sup>Ac-PSMA (Prostate-Specific Membrane Antigen).
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.531660
- By:
- Publication type:
- Article
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987654
- By:
- Publication type:
- Article
Combining liquid biopsy and functional imaging analysis in metastatic castration‐resistant prostate cancer helps predict treatment outcome.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 2, p. 538, doi. 10.1002/1878-0261.13120
- By:
- Publication type:
- Article
Theragnostic in neuroendocrine tumors.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 342, doi. 10.23736/S1824-4785.21.03426-9
- By:
- Publication type:
- Article
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987654
- By:
- Publication type:
- Article
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 10, p. 3260, doi. 10.1007/s00259-021-05236-z
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2035, doi. 10.1007/s00259-018-4067-3
- By:
- Publication type:
- Article
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 3, p. 348, doi. 10.1007/s00259-017-3866-2
- By:
- Publication type:
- Article
Reduction of Ga-PSMA renal uptake with mannitol infusion: preliminary results.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 13, p. 2189, doi. 10.1007/s00259-017-3791-4
- By:
- Publication type:
- Article
Peptide receptor radionuclide therapy with Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and F-FDG PET.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 6, p. 1040, doi. 10.1007/s00259-015-3262-8
- By:
- Publication type:
- Article
Feasibility and utility of re-treatment with Lu-DOTATATE in GEP-NENs relapsed after treatment with Y-DOTATOC.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 13, p. 1955, doi. 10.1007/s00259-015-3105-7
- By:
- Publication type:
- Article
F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 8, p. 1276, doi. 10.1007/s00259-015-3042-5
- By:
- Publication type:
- Article
Erratum to: F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
FDG PET/CT in autoimmune pancreatitis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 6, p. 1264, doi. 10.1007/s00259-014-2699-5
- By:
- Publication type:
- Article
Diagnostic and Prognostic Potential of <sup>18</sup>F-FET PET in the Differential Diagnosis of Glioma Recurrence and Treatment-Induced Changes After Chemoradiation Therapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.721821
- By:
- Publication type:
- Article
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 878, doi. 10.3390/cancers15030878
- By:
- Publication type:
- Article
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5680, doi. 10.3390/cancers14225680
- By:
- Publication type:
- Article
Radiomics Analysis on [ 68 Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE Trial.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1888, doi. 10.3390/cancers14081888
- By:
- Publication type:
- Article
Non-FDG PET in the practice of oncology.
- Published in:
- Indian Journal of Cancer, 2010, v. 47, n. 2, p. 120, doi. 10.4103/0019-509X.62998
- By:
- Publication type:
- Article
68 Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy.
- Published in:
- Biomedicines, 2020, v. 8, n. 12, p. 536, doi. 10.3390/biomedicines8120536
- By:
- Publication type:
- Article
SUV<sub>95th</sub> as a Reliable Alternative to SUV<sub>max</sub> for Determining Renal Uptake in [<sup>68</sup>Ga] PSMA PET/CT.
- Published in:
- 2020
- By:
- Publication type:
- journal article